01 22GILEAD SCIENCES INC
01 27390791
02 28754065
03 29216996
04 29296769
05 29708342
06 29732092
07 210385067
08 110548846
09 111744802
10 27390791*PED
11 28754065*PED
12 29296769*PED
01 12Y
02 10Blank
01 14Y
02 8Blank
01 22025-04-17
02 22025-10-17
03 42032-08-15
04 42033-02-15
05 42033-12-19
06 42035-06-19
07 22036-11-08
Patent Expiration Date : 2032-08-15
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2035-06-19
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 10385067
Drug Substance Claim :
Drug Product Claim :
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2035-06-19
Patent Expiration Date : 2032-08-15
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2035-06-19
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 10385067
Drug Substance Claim :
Drug Product Claim :
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2035-06-19
Patent Expiration Date : 2033-12-19
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9216996
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-12-19
Patent Expiration Date : 2036-11-08
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 11744802
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210251
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-11-08
Patent Expiration Date : 2033-12-19
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9732092
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-12-19
Patent Expiration Date : 2025-04-17
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 7390791
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-17
LOOKING FOR A SUPPLIER?
